The Visa and Starbucks-backed payment technology provider priced its shares at $9, a good deal below the $11 to $13 range set earlier this month.

Pandora is paying $75m for assets owned by Rdio, which had raised more than $125m from backers including Skype but has now filed for bankruptcy.

The Cephalon-backed stem cell therapy developer had been listed in Australia since 2004, and also counts Celgene as a shareholder.

Qualcomm, Autodesk, Alexander Schneider and Israel Electric Company were among the existing investors in a $60m acquisition by utility Direct Energy.

Instructure, developer of learning management platform Canvas, raises $80.96m in IPO.

Xiaomi, JD.com, Coca Cola and O'Reilly Media have exited the wearable device maker, which had raised $63m in VC funding over a three-year period.

The Sanofi-backed gene therapy company floated below its $15 to $17 range, but its shares have since risen to $17.50.

Biopharmaceutical company Wave Life Sciences has gone public at the middle of its range just nine months after closing its $18m SNBL-led series A round.

The Intel-backed mobile marketing company has now raised more than $50m in total, and has acquired data automation platform Adaptive.io.

Rocket Internet-backed meal delivery service HelloFresh hoped to raise around $332m from an initial public offering.